A continuing medical education and nursing continuing professional development activity provided by NAMCP and AAMCN.
This activity is an archive from the live session from the 2025 Spring Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.
This activity is valid from August 1, 2025 to August 1, 2026
Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the evaluation and post test. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete it. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate. To print or save your certificate, you will need to click on the "download" button after completing the post test.
Audience: This activity is intended for healthcare professionals practicing in managed care environments.
This activity is supported by an educational grant from
Vertex Pharmaceuticals
Description:
Every year in the United States, over 80 million people are prescribed medication for acute pain. Without adequate understanding of pain assessments, pain conditions, or their treatments, these patients may continue to experience diminished quality of life or chronic pain. Of these patients, about 40 million are prescribed an opioid. Nearly 10% of acute pain patients treated initially with an opioid will go on to have prolonged opioid use, and about 85,000 patients will develop opioid use disorder annually. Poorly controlled acute pain can lead to reduced quality of life, development of chronic pain, and increased clinical and economic burden on the health care system and society. Fortunately for patients that will deal with acute pain, new and emerging therapies, including non-opioid, highly selective pain signal inhibitors, have recently been approved, giving managed care professionals and clinicians more options for treating acute pain for the first time in decades. With new therapies entering the treatment paradigm with different mechanisms of action, knowledge gaps have been created, making it imperative that managed care physician medical directors, primary care physicians, emergency physicians, pharmacists, payers, nurses and other healthcare professionals who manage EC patient populations have a solid understanding of these options to optimize both costs and patient outcomes in their therapeutic application, for optimized clinical and economic outcomes.
Initiating therapies that address the underlying pathophysiology of pain can lead to improved pain control and avoid risks associated with conventional therapies, such as addiction with opioids. Emerging therapies for pain management focus on novel targets within the pain signaling pathways to provide effective pain relief with fewer adverse effects, but these multimodal, non-opioid therapies are often underused. In this live session and enduring materials, expert faculty will share perspectives on both managed care professionals and clinician involvement in medication reconciliation and the management of acute pain, considering top challenges regarding treatment modalities. It is critical that managed care professionals are brought up to date on these new options in order to ensure they are ready for approvals and utilization within their organizations.
Upon completion of this activity, participants will be able to:
Faculty:
Jeffrey Gudin, MD
Professor, Department of Anesthesiology, Perioperative Medicine and Pain Management
University of Miami, Miller School of Medicine
pain2dr@yahoo.com
Disclosure Information:
As accredited providers, NAMCP and AAMCN must ensure balance, independence, objectivity, and scientific rigor in all of their activities. All faculty participating in this activity are required to disclose to NAMCP/AAMCN any financial relationships with ineligible companies. NAMCP/AAMCN in turn discloses all relevant financial conflicts to the learners. NAMCP/AAMCN disclosure policy adheres to The Standards for Integrity and Independence in Accredited Continuing Education. All relevant conflicts of interest have been mitigated prior to the commencement of the activity. See below for conflicts of interest.
Disclosures (Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Dr. Gudin has served as a consultant for Collegium, Hisamitsu, Sanofi, and Tris. All relevant financial relationships have been mitigated.
Planning Committee Disclosures (Relevant Financial Relationships with Ineligible Companies in the Last 24 Months):
Bill Williams, MD has no relevant financial relationship with an ineligible company to disclose.
Jeremy Williams has no relevant financial relationship with an ineligible company to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationship with an ineligible company to disclose.
NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each physician should claim credit commensurate with the extent of their participation in the activity.
The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.
NAMCP and/or this website do not provide medical advice, diagnosis, or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health-related concern, consult with your physician or healthcare professional.
This activity is supported by an educational grant from
Vertex Pharmaceuticals
NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.